Wang Cong, Kong Dewei, Song Huiling, Liu Jiajia, Qi Manman, Li Longxuan
Postgraduate Training Base at Shanghai Gongli Hospital, Ningxia Medical University, Shanghai, P. R. China.
The Second People's Hospital of Nantong, Nantong, Jiangsu Province, P. R. China.
World Neurosurg. 2023 May;173:e329-e340. doi: 10.1016/j.wneu.2023.02.047. Epub 2023 Feb 14.
Moyamoya disease (MMD) is a rare cerebrovascular disease in neurology. This study investigates the literature related to MMD from its discovery to the present and identifies research levels, achievements, and trends.
All publications on MMD from its discovery to present were downloaded from the Web of Science Core Collection on September 15, 2022 and bibliometric analyses were visualized by HistCite Pro, VOSviewer, Scimago Graphica, CiteSpace, and R language.
There were 3414 articles in 680 journals by 10,522 authors in 2441 institutions and 74 countries/regions worldwise are included in the analyses. Since the discovery of MMD, output of publications has shown an upward trend. Japan, the United States, China, and South Korea are 4 major countries in MMD. The United States has the strongest cooperation with other countries. China's Capital Medical University is the output-leading institution worldwide, followed by Seoul National University and Tohoku University. The 3 authors with the most published articles are Kiyohiro Houkin, Dong Zhang, and Satoshi Kuroda. World Neurosurgery, Neurosurgery, and Stroke are the most recognized journals for researchers. Hemorrhagic moyamoya disease, susceptibility gene, and arterial spin are the primary focus areas of MMD research. "Rnf213,""vascular disorder," and "progress" are the top keywords.
We analyzed publications of global scientific research on MMD systematically by bibliometric methods. This study can provide one of the most comprehensive and accurate analyses for MMD scholars worldwide.
烟雾病（MMD）是神经学领域一种罕见的脑血管疾病。本研究调查了从烟雾病发现至今的相关文献，并确定了研究水平、成果和趋势。
从2022年9月15日的科学网核心合集中下载了从烟雾病发现至今的所有相关出版物，并通过HistCite Pro、VOSviewer、Scimago Graphica、CiteSpace和R语言对文献计量分析进行可视化处理。
分析纳入了来自2441个机构、74个国家/地区的10522名作者在680种期刊上发表的3414篇文章。自烟雾病被发现以来，出版物的产出呈上升趋势。日本、美国、中国和韩国是烟雾病研究的4个主要国家。美国与其他国家的合作最为紧密。中国首都医科大学是全球产出领先的机构，其次是首尔国立大学和东北大学。发表文章最多的3位作者是堀口清宏、张东和黑田聪。《世界神经外科杂志》《神经外科杂志》和《中风》是研究人员最认可的期刊。出血性烟雾病、易感基因和动脉自旋是烟雾病研究的主要重点领域。“Rnf213”“血管疾病”和“进展”是排名靠前的关键词。
我们通过文献计量方法系统分析了全球烟雾病科学研究的出版物。本研究可为全球烟雾病学者提供最全面、准确的分析之一。
